Table 2.
HRs of cytogenetic and clinical markers for event-free, relapse-free, and overall survival in multivariate analysis
| HR | 95% CI | P (χ2) | |
|---|---|---|---|
| NCK-7 positive (n = 61) | |||
| EFS | 1.69 | 1.04-2.76 | .035 |
| RFS | 2.26 | 1.15-4.48 | .019 |
| OS | 2.33 | 1.36-3.99 | .002 |
| Hyperdiploidy (n = 33) | |||
| EFS | 0.43 | 0.21-0.90 | .026 |
| RFS | 0.43 | 0.16-1.14 | .090 |
| OS | 0.44 | 0.20-1.01 | .053 |
| 7p-abnormality (n = 13) | |||
| EFS | 1.06 | 0.41-2.73 | .909 |
| RFS | 1.35 | 0.39-4.70 | .639 |
| OS | 1.10 | 0.38-3.17 | .860 |
| Normal karyotype (n = 20) | |||
| EFS | 0.85 | 0.43-1.70 | .651 |
| RFS | 0.98 | 0.40-2.43 | .966 |
| OS | 0.97 | 0.47-2.01 | .928 |
| Sex (male, n = 70) | |||
| EFS | 1.32 | 0.86-2.23 | .186 |
| RFS | 1.14 | 0.60-2.16 | .688 |
| OS | 1.41 | 0.84-2.38 | .193 |
| Age <2 y (n = 97) | |||
| EFS | 0.71 | 0.43-1.15 | .159 |
| RFS | 0.57 | 0.30-1.10 | .093 |
| OS | 0.82 | 0.49-1.38 | .453 |
| WBC count >20.0 × 109/L (n = 38) | |||
| EFS | 1.32 | 0.80-2.20 | .276 |
| RFS | 1.67 | 0.86-3.25 | .129 |
| OS | 1.62 | 0.95-2.76 | .079 |
| HSCT (n = 63) | |||
| EFS | 1.14 | 0.61-2.11 | .680 |
| RFS | 0.95 | 0.47-1.92 | .882 |
| OS | 1.18 | 0.67-2.08 | .575 |